Davidson Kempner Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-206,844
| Closed | -$8.31M | – | 196 |
|
|
2025
Q1 | $8.31M | Buy |
206,844
+27,783
| +16% | +$1.12M | 0.14% | 122 |
|
|
2024
Q4 | $8.42M | Sell |
179,061
-23,981
| -12% | -$1.13M | 0.16% | 111 |
|
|
2024
Q3 | $10.7M | Buy |
203,042
+76,604
| +61% | +$4.04M | 0.23% | 94 |
|
|
2024
Q2 | $6.84M | Buy |
126,438
+89,563
| +243% | +$4.84M | 0.11% | 128 |
|
|
2024
Q1 | $2.58M | Buy |
+36,875
| New | +$2.58M | 0.03% | 151 |
|